235 related articles for article (PubMed ID: 506998)
1. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
[TBL] [Abstract][Full Text] [Related]
2. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
Washington JA II
J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
[TBL] [Abstract][Full Text] [Related]
3. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
Goering RV; Sanders CC; Sanders W
J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of cefamandole.
Bodey GP; Weaver S
Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
[TBL] [Abstract][Full Text] [Related]
5. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
Menzies RE; Cornere BM; MacCulloch D
Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
[TBL] [Abstract][Full Text] [Related]
6. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
[TBL] [Abstract][Full Text] [Related]
7. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
8. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.
Digranes A; Bjorvatn B
NIPH Ann; 1980 Dec; 3(2):141-7. PubMed ID: 7219840
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
11. In vitro experience with cefonicid.
Actor P
Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
[TBL] [Abstract][Full Text] [Related]
12. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
[TBL] [Abstract][Full Text] [Related]
13. Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.
Barry AL; Schoenknecht FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
Antimicrob Agents Chemother; 1979 Jan; 15(1):140-1. PubMed ID: 106770
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
15. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
Eickhoff TC; Ehret JM
Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Braveny I; Dickert H; Machka K
Infection; 1979; 7(5):231-6. PubMed ID: 389804
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
[TBL] [Abstract][Full Text] [Related]
19. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
Uete T; Matsuo K
Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
[TBL] [Abstract][Full Text] [Related]
20. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
